2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
ContributorsFarge, Dominique; Frere, Corinne; Connors, Jean M; Ay, Cihan; Khorana, Alok A; Munoz, Andres; Brenner, Benjamin; Kakkar, Ajay; Rafii, Hanadi; Solymoss, Susan; Brilhante, Dialina; Monreal, Manuel; Bounameaux, Henri; Pabinger, Ingrid; Douketis, James; International Initiative on Thrombosis and Cancer (ITAC) advisory panel
Published inThe Lancet Oncology, vol. 20, no. 10, p. e566-e581
Publication date2019
Abstract
Keywords
- Anticoagulants/administration & dosage/therapeutic use
- Central Venous Catheters/adverse effects
- Factor Xa Inhibitors/therapeutic use
- Fondaparinux/therapeutic use
- Heparin, Low-Molecular-Weight/administration & dosage/therapeutic use
- Humans
- Neoplasms/complications/surgery
- Vena Cava Filters
- Venous Thromboembolism/drug therapy/etiology/prevention & control
- Vitamin K/antagonists & inhibitors
Affiliation
Research group
Citation (ISO format)
FARGE, Dominique et al. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. In: The Lancet Oncology, 2019, vol. 20, n° 10, p. e566–e581. doi: 10.1016/S1470-2045(19)30336-5
Main files (1)
Article (Published version)
Secondary files (1)
Identifiers
- PID : unige:147133
- DOI : 10.1016/S1470-2045(19)30336-5
- PMID : 31492632
ISSN of the journal1470-2045